Évolution de la prise en charge et du pronostic de l'infarctus du myocarde en France entre 1995 et 2000 : résultats des études USIK 1995 et USIC 2000

@article{Cambou2004volutionDL,
  title={{\'E}volution de la prise en charge et du pronostic de l'infarctus du myocarde en France entre 1995 et 2000 : r{\'e}sultats des {\'e}tudes USIK 1995 et USIC 2000},
  author={J. P. Cambou and Nicolas Danchin and Y. Boutalbi and Guy Hanania and Roger Humbert and Pierre Clerson and Laurent Vaur and P. Gu{\'e}ret and Didier Blanchard and N. Gen{\`e}s and Jean M. Lablanche},
  journal={Annales De Cardiologie Et D Angeiologie},
  year={2004},
  volume={53},
  pages={12-17}
}
View via Publisher
6 Citations

6 Citations

Citation Type

Citation Type

[Acute myocardial infarction in Djibouti: 2-year prospective study].
TLDR
Patients with AMI in Djibouti are 10 to 15 years younger than in Western countries and their high level of cardiovascular risk is remarkable, similar to rates reported before the percutaneous coronary angioplasty era.
Prise en charge thérapeutique de l'insuffisance cardiaque et de la dysfonction ventriculaire gauche post-infarctus du myocarde dans les unités de soins intensifs en cardiologie française
Place des glitazones dans de futures recommandations cliniques
Particularités des syndromes coronariens aigus chez la femme en Afrique subsaharienne
Prévention secondaire après syndrome coronaire aigu sans sus-décalage de ST en fonction de l'utilisation de l'angioplastie coronaire : l'étude S-Témoin
Chapitre 28 – Complications Vasculaires du Diabète

References

SHOWING 1-10 OF 13 REFERENCES
Efficacité du traitement de reperfusion au stade aigu de l'infarctus dans la population âgée : données du registre USIK 1995
Évolution du traitement de sortie après hospitalisation pour syndrome coronaire aigu en France entre 1995 et 2000 : données des études Usik 1995, Prévenir 1 et 2 et Usic 2000
Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results.
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
TLDR
Long-term treatment with trandolapril in patients with reduced left ventricular function soon after myocardial infarction significantly reduced the risk of overall mortality, mortality from cardiovascular causes, sudden death, and the development of severe heart failure.
GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)
A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.
TLDR
A strategy for reperfusion involving the transfer of patients to an invasive-treatment center for primary angioplasty is superior to on-site fibrinolysis, provided that the transfer takes two hours or less.
Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study
Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "real world": one-year results from a nationwide French survey.
TLDR
The results of this large registry of real-world practice indicate no survival benefit for patients treated with primary angioplasty compared with those who received thrombolytic therapy.
ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction
...
1
2
...